1) The document discusses platinum-based chemotherapy for ovarian cancer, which has a high response rate but most patients eventually relapse.
2) Two large randomized trials (GOG-0218 and ICON-7) found that adding bevacizumab to first-line platinum-based chemotherapy improved progression-free survival compared to chemotherapy alone in patients with advanced ovarian cancer.
3) For platinum-sensitive recurrent ovarian cancer, platinum-based chemotherapy regimens including carboplatin or cisplatin with paclitaxel are commonly used based on evidence from trials like ICON-4 that they provide a similar overall survival benefit.
This randomized controlled trial investigated the effects of long-term simvastatin therapy in reducing mortality and coronary events in 4,444 patients with coronary artery disease. Patients received either simvastatin 20-40 mg/day or placebo. The study found that simvastatin reduced total mortality by 30%, coronary mortality by 42%, and major coronary events such as heart attack by 34% compared to placebo. Simvastatin also reduced the need for procedures like angioplasty or bypass surgery by 37% and improved long-term survival free from cardiovascular events by 26%. Simvastatin significantly lowered LDL cholesterol and total cholesterol levels.
This presentation discusses two of YM BioSciences' principal drug development assets, Nimotuzumab and AeroLEF. Nimotuzumab is an EGFR-targeting drug that has demonstrated efficacy in multiple cancer types through over 30 clinical trials. It has a differentiated mechanism of action compared to other EGFR antibodies and a superior safety profile with no severe skin or kidney toxicities reported. AeroLEF is a novel self-titrating opioid delivery system for acute post-operative pain. The presentation provides clinical evidence for the drugs and outlines YM BioSciences' strategy for advancing their regulatory approval and commercialization.
The document summarizes Craig Karr's presentation on drug discovery tools for glycobiologists given at the Cambridge Healthtech Institute Glycomics conference in April 2004. Karr discussed a high throughput biochemistry approach to drug discovery using parallel target discovery and screening efforts. This includes developing a platform to rapidly profile and deorphan novel glycosyltransferase targets derived from glycomics using peptide arrays and enzymatic assays. Validation results were shown for several human glycosyltransferases.
The document summarizes chemotherapy options for bladder cancer patients. It discusses standard first-line treatments for "fit" patients like gemcitabine/cisplatin and MVAC, and trials comparing these regimens. For "unfit" patients unable to receive cisplatin, it presents a randomized phase II/III trial comparing gemcitabine/carboplatin to methotrexate/carboplatin/vinblastine which showed similar efficacy and toxicity between the arms. The trial helped establish an option for treating this patient population.
- A 54-year-old man presented to a non-PCI hospital with chest pain and was found to have an ST-elevation myocardial infarction (STEMI) involving the inferior wall and right ventricular myocardial infarction.
- The nearest catheterization laboratory was 30 minutes away. The patient suffered a ventricular fibrillation cardiac arrest and received CPR and defibrillation.
- The patient was transferred for primary percutaneous coronary intervention (PPCI). Angiography showed 100% occlusion of the proximal right coronary artery, which was treated with balloon angioplasty, stent placement, and achieved TIMI III flow, resulting in successful reperfusion.
The Use of Achieve Circular Mapping Catheter Significantly Reduces Procedure ...Jc Templar
Michaël Peyrol, Pascal Sbragia, Morgane Orabona, Anne-Claire Casalta, Amandine Quatre, Zinedine Zerrouk, Gilles Boccara, Maxime Guenoun, Samuel Lévy, Franck Paganelli
Department of Cardiology, Centre Hospitalier Universitaire Nord, Marseille, France
CARCINOMA OVARY- EARLY STAGE MANAGEMENTNabeel Yahiya
This document discusses staging, treatment, and survival rates for ovarian cancer. It notes that over 70% of patients present with advanced stage III or IV disease, and less than 40% of women are cured. Primary treatment consists of surgical staging and cytoreduction followed by chemotherapy. Platinum-based chemotherapy, particularly carboplatin and paclitaxel, is now the standard first-line treatment and has improved progression-free and overall survival rates compared to previous single agents or regimens. Adjuvant chemotherapy is also now recommended for early stage high risk disease to further reduce relapse rates.
This randomized controlled trial investigated the effects of long-term simvastatin therapy in reducing mortality and coronary events in 4,444 patients with coronary artery disease. Patients received either simvastatin 20-40 mg/day or placebo. The study found that simvastatin reduced total mortality by 30%, coronary mortality by 42%, and major coronary events such as heart attack by 34% compared to placebo. Simvastatin also reduced the need for procedures like angioplasty or bypass surgery by 37% and improved long-term survival free from cardiovascular events by 26%. Simvastatin significantly lowered LDL cholesterol and total cholesterol levels.
This presentation discusses two of YM BioSciences' principal drug development assets, Nimotuzumab and AeroLEF. Nimotuzumab is an EGFR-targeting drug that has demonstrated efficacy in multiple cancer types through over 30 clinical trials. It has a differentiated mechanism of action compared to other EGFR antibodies and a superior safety profile with no severe skin or kidney toxicities reported. AeroLEF is a novel self-titrating opioid delivery system for acute post-operative pain. The presentation provides clinical evidence for the drugs and outlines YM BioSciences' strategy for advancing their regulatory approval and commercialization.
The document summarizes Craig Karr's presentation on drug discovery tools for glycobiologists given at the Cambridge Healthtech Institute Glycomics conference in April 2004. Karr discussed a high throughput biochemistry approach to drug discovery using parallel target discovery and screening efforts. This includes developing a platform to rapidly profile and deorphan novel glycosyltransferase targets derived from glycomics using peptide arrays and enzymatic assays. Validation results were shown for several human glycosyltransferases.
The document summarizes chemotherapy options for bladder cancer patients. It discusses standard first-line treatments for "fit" patients like gemcitabine/cisplatin and MVAC, and trials comparing these regimens. For "unfit" patients unable to receive cisplatin, it presents a randomized phase II/III trial comparing gemcitabine/carboplatin to methotrexate/carboplatin/vinblastine which showed similar efficacy and toxicity between the arms. The trial helped establish an option for treating this patient population.
- A 54-year-old man presented to a non-PCI hospital with chest pain and was found to have an ST-elevation myocardial infarction (STEMI) involving the inferior wall and right ventricular myocardial infarction.
- The nearest catheterization laboratory was 30 minutes away. The patient suffered a ventricular fibrillation cardiac arrest and received CPR and defibrillation.
- The patient was transferred for primary percutaneous coronary intervention (PPCI). Angiography showed 100% occlusion of the proximal right coronary artery, which was treated with balloon angioplasty, stent placement, and achieved TIMI III flow, resulting in successful reperfusion.
The Use of Achieve Circular Mapping Catheter Significantly Reduces Procedure ...Jc Templar
Michaël Peyrol, Pascal Sbragia, Morgane Orabona, Anne-Claire Casalta, Amandine Quatre, Zinedine Zerrouk, Gilles Boccara, Maxime Guenoun, Samuel Lévy, Franck Paganelli
Department of Cardiology, Centre Hospitalier Universitaire Nord, Marseille, France
CARCINOMA OVARY- EARLY STAGE MANAGEMENTNabeel Yahiya
This document discusses staging, treatment, and survival rates for ovarian cancer. It notes that over 70% of patients present with advanced stage III or IV disease, and less than 40% of women are cured. Primary treatment consists of surgical staging and cytoreduction followed by chemotherapy. Platinum-based chemotherapy, particularly carboplatin and paclitaxel, is now the standard first-line treatment and has improved progression-free and overall survival rates compared to previous single agents or regimens. Adjuvant chemotherapy is also now recommended for early stage high risk disease to further reduce relapse rates.
Ovarian cancer is a leading cause of death from gynecologic cancers. Chemotherapy plays an important role in its treatment. For advanced stage disease, the standard treatment is 6 cycles of carboplatin and paclitaxel chemotherapy. Neoadjuvant chemotherapy may be given for very advanced cases to allow for optimal debulking surgery. Prognostic factors like residual tumor size after surgery and tumor stage help determine prognosis and treatment. Maintenance chemotherapy may improve progression-free survival for high risk early stage disease.
Downloadable slide decks are a great tool for self study and teaching purposes. They are non-certified resources available to enhance your knowledge.
Review a downloadable slide deck by Deborah K. Armstrong, MD, covering the most clinically relevant new data reported from The Future of Antiangiogenic Therapies in Ovarian Cancer: A Series of Community and Academic Grand Rounds.
Target Audience
This activity has been designed to meet the unique learning needs of oncologists, surgeons, gynecologists, and other healthcare professionals involved in the treatment of patients with ovarian cancer.
Format: Microsoft PowerPoint (.ppt) | File size: 9.7 MB | Date posted: 8/06/2012
Slide Deck Disclaimer
This slide deck in its original and unaltered format is for educational purposes and is current as of August 2012. All materials contained herein reflect the views of the faculty, and not those of IMER, the CME provider, or the commercial supporter. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. Readers should not rely on this information as a substitute for professional medical advice, diagnosis, or treatment. The use of any information provided is solely at your own risk, and readers should verify the prescribing information and all data before treating patients or employing any therapeutic products described in this educational activity.
Usage Rights
This slide deck is provided for educational purposes and individual slides may be used for personal, non-commercial presentations only if the content and references remain unchanged. No part of this slide deck may be published in print or electronically as a promotional or certified educational activity without prior written permission from IMER. Additional terms may apply. See Terms of Service on IMERonline.com for details.
Activity Overview
Although progress continues to be made in the treatment of ovarian cancer, making clinical decisions remains a challenge due to the many treatment options available in several different settings. Selective inhibitors of the VEGF/PDGF/FGF pathways have shown activity in patients with ovarian cancer in phase II and III clinical trials either as monotherapy or in combination with other chemotherapy. Community and academic oncologists who treat patients with ovarian cancer need to stay abreast of the latest research that can affect treatment decisions and patient outcomes.
As controversy still exists regarding how and when to incorporate the use of antiangiogenic agents into the treatment paradigm for ovarian cancer patients, this case-based activity developed by expert faculty will provide clinicians with the practical application of new data into community and academic practice settings.
The document discusses several controversies in treating recurrent ovarian cancer, including:
1) The role of monitoring CA-125 levels and whether chemotherapy should be initiated based on a rising CA-125 alone without other evidence of disease.
2) The potential benefit of secondary cytoreduction surgery for some patients with recurrent disease.
3) Determining optimal treatment approaches for platinum-sensitive versus platinum-resistant recurrent ovarian cancer.
Acoustic Correction of High School gym in Florencearchisonus
This is a short powerpoint presentation about the acoustic correction of High School gym in Florence, Italy. The project wants to be an example of coexisting activities between sport and oral activities.
Santo Tomás es un municipio en el departamento de Atlántico, Colombia. Es conocido como "el municipio verde del Atlántico" debido a su gran número de árboles de mango. Los habitantes de Santo Tomás se caracterizan por ser trabajadores, responsables y respetuosos. Celebran tradiciones culturales como los carnavales y la Semana Santa, que refuerzan los valores comunitarios y el respeto por el patrimonio.
Realtech Consulting Webinar about SAP Migrations worldwide
- Migration source platforms are overwhelmingly UNIX (more than 90%)
- Migration target platforms are Linux (58%) and Windows (27%)
- No Limits in terms of SAP workloads to be migrated
This document provides tips and tools for using the web as a research tool. It lists various search engines, social media search functions, and other websites that can be used to find information on the web. Advanced search techniques for major search engines like Google are also outlined. The document encourages developing a research plan and approaching information critically online. A variety of people search tools and archives of past web pages and content are also listed.
This document provides an overview of computers including:
- A definition of a computer as an electronic machine that receives and processes data.
- A brief history of early calculating devices like the abacus and Pascal's mechanical calculator, leading to the first modern computer - the Mark 1 built in 1944.
- Descriptions of key computer components like the central processing unit, memory, storage devices, and input/output components.
- An explanation of key computer characteristics such as speed, accuracy, reliability, and storage capabilities. It also discusses capabilities like processing large amounts of data quickly as well as limitations like a lack of self-intelligence.
This document summarizes an experiment on small group dynamics using a virtual interaction environment. It included three conditions: a minority voting game with no consensus strategy, a blank interaction with no task, and a majority voting game. The experiment aimed to characterize how communication networks and affinities form in small groups. It used an interface dividing interaction between public chat and private messages, and public/private radar spaces to manipulate positions. Order parameters like activity, centrality degree, and probability matrices were used to analyze communication structure and relationships over time. The results were intended to capture fundamental aspects of individual behavior in small group virtual dynamics.
This document discusses various methods for securing a WordPress site, including updating plugins and themes regularly, using strong credentials, limiting login attempts, installing security plugins, implementing two-factor authentication, scanning for malware, restricting admin access by IP address, optimizing database security, and using caching plugins to improve page speed. The document emphasizes the importance of security for protecting site visitors and reducing costs and outlines both basic and advanced security measures to lock down a WordPress site.
Get the PLM Training and Services from PTC Authorized Training center in ...CMS Computer
This short document promotes creating presentations using Haiku Deck, a tool for making slideshows. It encourages the reader to get started making their own Haiku Deck presentation and sharing it on SlideShare. In just one sentence, it pitches the idea of using Haiku Deck to easily create engaging slideshows.
Valutek introduces new pre-wetted wipes that allow customers to choose any wipe substrate, solvent blend, and concentration. Their wipes are vacuum-packed for long shelf life and easy dispensing. Valutek also offers nitrile gloves as a cleaner alternative to latex gloves. Their nitrile gloves generate fewer particles and reduce the risk of allergic reactions. Additionally, Valutek presents adhesive mats made with an eco-friendly water-based adhesive that has a softer surface to better retain particles.
Texas has the second largest population and size among U.S. states. The climate varies greatly from hot and dry in the west to hot and humid in the east. Major industries include energy, aeronautics, technology, and agriculture. Famous Texans include Willie Nelson, Janis Joplin, and Lyndon B. Johnson. The state's capital is Austin.
Este documento trata sobre los valores y su importancia. Define los valores como guías de comportamiento que regulan la conducta de un individuo e influyen en sus decisiones. Explica que los valores personales y éticos adquiridos desde la familia son herramientas para ser una mejor persona. Finalmente, señala que al conocer y practicar valores en diferentes etapas de la vida, como los de la universidad, se puede desarrollar de manera integral para ejercer la profesión de manera responsable.
The document is a short advertisement for the presentation creation tool Haiku Deck. It encourages the reader to get started creating their own Haiku Deck presentation on SlideShare by simply clicking the "GET STARTED" button shown in the image. A Haiku Deck presentation allows users to easily design beautiful, visual presentations.
This document discusses treatment approaches for locally advanced non-small cell lung cancer (NSCLC). It presents a case of stage IIIB NSCLC and reviews the history and evolution of combined modality therapy using chemotherapy and radiotherapy. Concurrent chemoradiotherapy is now the standard of care and research focuses on optimizing radiotherapy dose/fractionation and integrating targeted therapies and prophylactic cranial irradiation to further improve outcomes.
The document summarizes information about lung cancer, including:
1) Lung cancer subtypes are small cell carcinoma (13%), large cell carcinoma (5%), adenocarcinoma (38.3%), and squamous cell carcinoma (19.7%).
2) Adjuvant chemotherapy in resected early-stage non-small cell lung cancer (NSCC) improves survival compared to surgery alone, though benefits vary by stage. Platinum-based regimens like cisplatin and vinorelbine are commonly used.
3) For locally advanced unresectable NSCLC, concurrent chemoradiotherapy is superior to sequential chemotherapy and radiotherapy, improving median and 5-year survival.
Ovarian cancer is a leading cause of death from gynecologic cancers. Chemotherapy plays an important role in its treatment. For advanced stage disease, the standard treatment is 6 cycles of carboplatin and paclitaxel chemotherapy. Neoadjuvant chemotherapy may be given for very advanced cases to allow for optimal debulking surgery. Prognostic factors like residual tumor size after surgery and tumor stage help determine prognosis and treatment. Maintenance chemotherapy may improve progression-free survival for high risk early stage disease.
Downloadable slide decks are a great tool for self study and teaching purposes. They are non-certified resources available to enhance your knowledge.
Review a downloadable slide deck by Deborah K. Armstrong, MD, covering the most clinically relevant new data reported from The Future of Antiangiogenic Therapies in Ovarian Cancer: A Series of Community and Academic Grand Rounds.
Target Audience
This activity has been designed to meet the unique learning needs of oncologists, surgeons, gynecologists, and other healthcare professionals involved in the treatment of patients with ovarian cancer.
Format: Microsoft PowerPoint (.ppt) | File size: 9.7 MB | Date posted: 8/06/2012
Slide Deck Disclaimer
This slide deck in its original and unaltered format is for educational purposes and is current as of August 2012. All materials contained herein reflect the views of the faculty, and not those of IMER, the CME provider, or the commercial supporter. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. Readers should not rely on this information as a substitute for professional medical advice, diagnosis, or treatment. The use of any information provided is solely at your own risk, and readers should verify the prescribing information and all data before treating patients or employing any therapeutic products described in this educational activity.
Usage Rights
This slide deck is provided for educational purposes and individual slides may be used for personal, non-commercial presentations only if the content and references remain unchanged. No part of this slide deck may be published in print or electronically as a promotional or certified educational activity without prior written permission from IMER. Additional terms may apply. See Terms of Service on IMERonline.com for details.
Activity Overview
Although progress continues to be made in the treatment of ovarian cancer, making clinical decisions remains a challenge due to the many treatment options available in several different settings. Selective inhibitors of the VEGF/PDGF/FGF pathways have shown activity in patients with ovarian cancer in phase II and III clinical trials either as monotherapy or in combination with other chemotherapy. Community and academic oncologists who treat patients with ovarian cancer need to stay abreast of the latest research that can affect treatment decisions and patient outcomes.
As controversy still exists regarding how and when to incorporate the use of antiangiogenic agents into the treatment paradigm for ovarian cancer patients, this case-based activity developed by expert faculty will provide clinicians with the practical application of new data into community and academic practice settings.
The document discusses several controversies in treating recurrent ovarian cancer, including:
1) The role of monitoring CA-125 levels and whether chemotherapy should be initiated based on a rising CA-125 alone without other evidence of disease.
2) The potential benefit of secondary cytoreduction surgery for some patients with recurrent disease.
3) Determining optimal treatment approaches for platinum-sensitive versus platinum-resistant recurrent ovarian cancer.
Acoustic Correction of High School gym in Florencearchisonus
This is a short powerpoint presentation about the acoustic correction of High School gym in Florence, Italy. The project wants to be an example of coexisting activities between sport and oral activities.
Santo Tomás es un municipio en el departamento de Atlántico, Colombia. Es conocido como "el municipio verde del Atlántico" debido a su gran número de árboles de mango. Los habitantes de Santo Tomás se caracterizan por ser trabajadores, responsables y respetuosos. Celebran tradiciones culturales como los carnavales y la Semana Santa, que refuerzan los valores comunitarios y el respeto por el patrimonio.
Realtech Consulting Webinar about SAP Migrations worldwide
- Migration source platforms are overwhelmingly UNIX (more than 90%)
- Migration target platforms are Linux (58%) and Windows (27%)
- No Limits in terms of SAP workloads to be migrated
This document provides tips and tools for using the web as a research tool. It lists various search engines, social media search functions, and other websites that can be used to find information on the web. Advanced search techniques for major search engines like Google are also outlined. The document encourages developing a research plan and approaching information critically online. A variety of people search tools and archives of past web pages and content are also listed.
This document provides an overview of computers including:
- A definition of a computer as an electronic machine that receives and processes data.
- A brief history of early calculating devices like the abacus and Pascal's mechanical calculator, leading to the first modern computer - the Mark 1 built in 1944.
- Descriptions of key computer components like the central processing unit, memory, storage devices, and input/output components.
- An explanation of key computer characteristics such as speed, accuracy, reliability, and storage capabilities. It also discusses capabilities like processing large amounts of data quickly as well as limitations like a lack of self-intelligence.
This document summarizes an experiment on small group dynamics using a virtual interaction environment. It included three conditions: a minority voting game with no consensus strategy, a blank interaction with no task, and a majority voting game. The experiment aimed to characterize how communication networks and affinities form in small groups. It used an interface dividing interaction between public chat and private messages, and public/private radar spaces to manipulate positions. Order parameters like activity, centrality degree, and probability matrices were used to analyze communication structure and relationships over time. The results were intended to capture fundamental aspects of individual behavior in small group virtual dynamics.
This document discusses various methods for securing a WordPress site, including updating plugins and themes regularly, using strong credentials, limiting login attempts, installing security plugins, implementing two-factor authentication, scanning for malware, restricting admin access by IP address, optimizing database security, and using caching plugins to improve page speed. The document emphasizes the importance of security for protecting site visitors and reducing costs and outlines both basic and advanced security measures to lock down a WordPress site.
Get the PLM Training and Services from PTC Authorized Training center in ...CMS Computer
This short document promotes creating presentations using Haiku Deck, a tool for making slideshows. It encourages the reader to get started making their own Haiku Deck presentation and sharing it on SlideShare. In just one sentence, it pitches the idea of using Haiku Deck to easily create engaging slideshows.
Valutek introduces new pre-wetted wipes that allow customers to choose any wipe substrate, solvent blend, and concentration. Their wipes are vacuum-packed for long shelf life and easy dispensing. Valutek also offers nitrile gloves as a cleaner alternative to latex gloves. Their nitrile gloves generate fewer particles and reduce the risk of allergic reactions. Additionally, Valutek presents adhesive mats made with an eco-friendly water-based adhesive that has a softer surface to better retain particles.
Texas has the second largest population and size among U.S. states. The climate varies greatly from hot and dry in the west to hot and humid in the east. Major industries include energy, aeronautics, technology, and agriculture. Famous Texans include Willie Nelson, Janis Joplin, and Lyndon B. Johnson. The state's capital is Austin.
Este documento trata sobre los valores y su importancia. Define los valores como guías de comportamiento que regulan la conducta de un individuo e influyen en sus decisiones. Explica que los valores personales y éticos adquiridos desde la familia son herramientas para ser una mejor persona. Finalmente, señala que al conocer y practicar valores en diferentes etapas de la vida, como los de la universidad, se puede desarrollar de manera integral para ejercer la profesión de manera responsable.
The document is a short advertisement for the presentation creation tool Haiku Deck. It encourages the reader to get started creating their own Haiku Deck presentation on SlideShare by simply clicking the "GET STARTED" button shown in the image. A Haiku Deck presentation allows users to easily design beautiful, visual presentations.
This document discusses treatment approaches for locally advanced non-small cell lung cancer (NSCLC). It presents a case of stage IIIB NSCLC and reviews the history and evolution of combined modality therapy using chemotherapy and radiotherapy. Concurrent chemoradiotherapy is now the standard of care and research focuses on optimizing radiotherapy dose/fractionation and integrating targeted therapies and prophylactic cranial irradiation to further improve outcomes.
The document summarizes information about lung cancer, including:
1) Lung cancer subtypes are small cell carcinoma (13%), large cell carcinoma (5%), adenocarcinoma (38.3%), and squamous cell carcinoma (19.7%).
2) Adjuvant chemotherapy in resected early-stage non-small cell lung cancer (NSCC) improves survival compared to surgery alone, though benefits vary by stage. Platinum-based regimens like cisplatin and vinorelbine are commonly used.
3) For locally advanced unresectable NSCLC, concurrent chemoradiotherapy is superior to sequential chemotherapy and radiotherapy, improving median and 5-year survival.
This document discusses gastric cancer staging, treatment, and clinical trials. It begins with an overview of TNM staging for gastric cancer. The main treatment approaches discussed are surgery, chemotherapy, and chemoradiotherapy in both adjuvant and neoadjuvant settings. Key clinical trials summarized include the MAGIC trial demonstrating improved survival with perioperative chemotherapy and the INT-0116 trial showing benefit of postoperative chemoradiotherapy. Later lines of chemotherapy discussed include regimens using fluoropyrimidines, platinum agents, taxanes, and irinotecan. The ToGA trial established the benefit of adding trastuzumab for HER2-positive gastric cancer.
This document discusses the changing landscape and treatment of lymphomas with a focus on the role of radiotherapy. Some key points:
- Non-Hodgkin lymphomas present many challenges due to their diversity and changing outcomes over time. Radiotherapy is an effective local therapy for tumor control and can cure localized disease.
- For stage I/II follicular lymphoma and mucosa-associated lymphoid tissue lymphoma, radiotherapy alone provides excellent long-term local control and survival.
- For localized diffuse large B-cell lymphoma, combined modality treatment with chemotherapy and radiotherapy improves outcomes. Ongoing studies are evaluating the role of radiotherapy in the rituximab era.
Ming-Der Yu has over 30 years of experience in radiochemistry and cyclotron operations. He received his PhD and MS from Purdue University and is currently working at the University Health Network in Toronto. His experience includes directing radiochemistry facilities, managing radiopharmacies, and developing radiotracer synthesis methods for PET imaging using radionuclides such as 18F, 11C, 13N, and 15O produced by a cyclotron. His work involves ensuring compliance with cGMP regulations for production of clinical radiotracers including FDG, FLT, FDOPA, and raclopride.
1) The document discusses a masterclass on non-small cell lung cancer (NSCLC) surgery.
2) It presents a case study of a 59-year-old female with an incidental chest X-ray finding and questions regarding her diagnosis, staging, and treatment options.
3) The document reviews NSCLC staging statistics, survival rates based on stage, and concepts in personalized and integrated therapy for NSCLC.
The fabrication of stimuli-responsive, multifunctional proteins comprised of self-assembling domains capable of forming defined nanometre scale structures has tremendous application in drug delivery. This coupled to inorganic material like Gold nanoparticles (GNP’s) can facilitate external triggers controlling binding and release of embedded agents within the self-assembling materials. This renders smart biomaterial suitable for drug delivery.
Best of ASCO Metastatic Non-Small Cell Lung CancerH. Jack West
Dr. Jack West's presentation on highlights in advanced non-small cell lung cancer from ASCO 2014, focusing on new agents ramucirumab and necitumumab for broad NSCLC populations, crizotinib and ceritinib for ALK-positive NSCLC, EGFR inhibitor-options of afatinib and bevacizumab added to erlotinib for first line treatment of EGFR mutation-positive NSCLC, and AZD9291 or CO1686 for EGFR mutation-positive patients with acquired resistance.
This document summarizes the treatment landscape for ovarian cancer. It discusses standard first-line treatment options including platinum-based chemotherapy with carboplatin and paclitaxel, as well as the importance of adequate surgery to remove as much of the tumor as possible. It also reviews several phase 3 clinical trials investigating the addition of angiogenesis inhibitors like bevacizumab to chemotherapy regimens. Trials like ICON7 and GOG 218 found improved progression-free survival when bevacizumab was added to first-line treatment. For recurrent disease, bevacizumab was also found to improve outcomes when added to chemotherapy in platinum-sensitive patients based on studies like OCEANS and GOG-213. Residual
Integration Of Targeted Therapies With Radiation Lung Cancerfondas vakalis
1) The document discusses integrating targeted therapies such as EGFR inhibitors and angiogenesis inhibitors with chemoradiotherapy for the treatment of stage III non-small cell lung cancer (NSCLC).
2) Several phase II trials showed that combining chemoradiotherapy with the EGFR inhibitor cetuximab was feasible and resulted in promising survival outcomes. This warrants a phase III trial.
3) Combining chemoradiotherapy with tyrosine kinase inhibitors and angiogenesis inhibitors like bevacizumab is also being explored, but data is still limited and complex trial designs make results difficult to interpret. Further research is still needed.
This document discusses radiotherapy (RT) for hepatocellular carcinoma (HCC) in the Asia-Pacific region. It compares outcomes between sorafenib and RT for intermediate/advanced HCC. Helical tomotherapy (HT) improves long-term survival and increases radiation dose without increased toxicity for HCC with macrovascular invasion compared to 3D conformal radiotherapy (3DCRT). HT allows delivery of higher radiation doses in a shorter treatment period with acceptable toxicity for HCC with macrovascular invasion.
This is an overview of the adjuvant Tx of pancreatic CA. A Lecture that was given in the annual conference of NCI Egypt: 45 years against cancer in Egypt. Cairo, April, 2013
1. The document discusses individualized systemic therapy for non-small cell lung cancer (NSCLC), focusing on biomarkers like ERCC1, BRCA1, and EGFR mutations that can help customize chemotherapy based on a patient's tumor genetics.
2. Clinical trials show that targeting therapies like EGFR tyrosine kinase inhibitors provide significant benefits for NSCLC patients with EGFR mutations, with response rates over 70% in some studies.
3. Ongoing research aims to identify additional biomarkers to further personalize treatment selection and overcome resistance to targeted therapies.
Role of systemic therapy in management of laryngeal carcinomaMohammed Fathy
This document discusses the role of systemic therapy in the management of laryngeal carcinoma. It begins with an introduction to chemotherapy and the goals of cancer treatment. It then reviews different chemotherapy regimens and targeted agents that have been studied in clinical trials for laryngeal cancer. It summarizes several landmark randomized controlled trials that have evaluated induction chemotherapy, concurrent chemoradiotherapy, and sequential chemoradiotherapy approaches. The document concludes by reviewing meta-analyses that have assessed the benefits of adding chemotherapy to radiotherapy for head and neck cancers.
1) Vinorelbine is an agent used in chemotherapy regimens for non-small cell lung cancer (NSCLC). Studies have shown vinorelbine combined with cisplatin improves survival compared to cisplatin alone.
2) The E1505 trial examined using adjuvant chemotherapy after surgery for NSCLC, including regimens of cisplatin combined with vinorelbine, docetaxel, or gemcitabine. It also explored adding bevacizumab to these regimens.
3) Results from the ECOG 4599 study showed that for advanced NSCLC, bevacizumab combined with paclitaxel and carboplatin improved median survival compared to paclitax
RR-17%
mPFS-4.5 mon
mOS-9.2 mon
Phase III trial
Rec/met HNSCC
N=326
Mtx vs Mtx+BV
No benefit
[1] The document discusses targeted therapies for head and neck squamous cell carcinoma (HNSCC).
[2] It summarizes genetic alterations commonly seen in HNSCC and targeted agents used to treat HNSCC including EGFR inhibitors like cetuximab, IGF inhibitors, VEGF receptor inhibitors, and other non-receptor targets.
[3] The document analyzes clinical trials of cetuximab, panitumumab
AJS: a lethal weapon to combat with cancers Treatment of Human Cancers Using...gan-navi
This document describes a lentiviral vector called AJS2001 that can selectively silence the Cdc6 gene in cancer cells. Cdc6 is essential for initiating DNA replication, and silencing it blocks cancer cell proliferation. The vector was shown to inhibit growth of several cancer cell lines through Cdc6 knockdown, inducing senescence. Case studies are presented of cancer patients who recovered after treatment with injections of AJS2001 lentivirus, including patients with gastric carcinoma, brain and liver metastases from ovarian cancer, lung and larynx metastases from parotid carcinoma, and breast cancer.
Early Stage Nsclc The Role Of Chemotherapyfondas vakalis
- The document discusses the role of chemotherapy in early stage non-small cell lung cancer (NSCLC), including adjuvant and induction chemotherapy.
- Several studies on induction chemotherapy found it to be safe and feasible prior to surgery, with high rates of tumor response and similar postoperative complications compared to surgery alone. However, larger phase III studies are still ongoing.
- The optimal use of chemotherapy, whether adjuvant or induction, in early stage NSCLC remains unclear and requires completion of current clinical trials.
Similar to 07 state of the art of the management of advanced and recurrent ovarian cancer (20)
50 fisiopatologia da desnutrição dos pacientes com câncer de estômago, cólo...ONCOcare
O documento discute a fisiopatologia da desnutrição em pacientes com câncer de estômago, cólon e pâncreas. A desnutrição é comum nesses pacientes, com taxas de prevalência variando de 30% a 85% dependendo do local do câncer. O câncer e seu tratamento podem causar anorexia, alterações metabólicas, déficits energéticos e distúrbios nos macronutrientes, levando à perda de peso. A desnutrição está associada a piores resultados do tratamento e sobrevida
O documento discute o manejo de eventos adversos no tratamento de quimioterapia, incluindo: (1) os principais eventos adversos como hematológicos, gastrointestinais e cardiotoxicidade; (2) detalhes sobre eventos gastrointestinais como mucosite, diarreia e náuseas/vômitos; e (3) recomendações para prevenção e tratamento desses eventos.
48 cirurgia citorredutora e quimioterapia intraperitoneal hipertérmica no t...ONCOcare
O documento discute o tratamento da carcinomatose peritoneal por câncer colorretal através da cirurgia citoredutora e quimioterapia intraperitoneal hipertérmica. A cirurgia citoredutora completa associada à quimioterapia intraperitoneal tem mostrado melhores resultados do que o tratamento sistêmico convencional em termos de sobrevida. Estudos prospectivos controlados são necessários para validar definitivamente essa abordagem.
47 trabalho em equipe multidisciplinar em cuidados paliativosONCOcare
Este documento descreve o caso de J.M.G., um homem de 54 anos diagnosticado com câncer de próstata em estágio avançado. Ele passou seus últimos meses de vida no hospice, onde buscou sentido através de relações com outros pacientes e equipe, e realizou uma homenagem às mães antes de falecer cercado por sua família.
46 tratamento da caquexia no paciente em cuidados paliativosONCOcare
O documento discute o tratamento da caquexia em pacientes em cuidados paliativos. Apresenta definições de cuidados paliativos e caquexia, sinais clínicos e mediadores bioquímicos da caquexia. Discute a importância do tratamento multidisciplinar, incluindo terapia nutricional e controle da dor, e o potencial papel do ômega-3 como suplemento nutricional.
45 a intervenção psicológica na terminalidade, voltada para paciente e famíliaONCOcare
O documento discute o processo de luto e as perdas decorrentes do diagnóstico e tratamento de doenças potencialmente fatais. Apresenta as cinco dimensões do luto (intelectual, emocional, física, espiritual e social) e destaca a importância do luto antecipatório para a elaboração gradual da perda. Também descreve seis objetivos para a construção de significado durante esse processo: encontrar novo significado na vida e morte, pontos de continuidade e transição, significados pré-verbais e explícitos,
44 hipodermóclise - aspectos gerais e indicaçõesONCOcare
O documento discute a hipodermóclise, que envolve a infusão contínua de fluidos no tecido subcutâneo para reposição hidroeletrolítica ou terapia medicamentosa. Apresenta as definições, mecanismo, anatomia da pele, histórico, indicações, vantagens, desvantagens, contraindicações, farmacocinética, técnica e cuidados com o dispositivo. Também lista medicamentos comuns administrados por esta via e exemplos de prescrições médicas.
O documento fornece orientações sobre cuidados paliativos no final da vida, enfatizando a importância de manter a dignidade do paciente, aliviar o sofrimento, apoiar os familiares e antecipar as mudanças durante o processo de morrer.
O documento apresenta estatísticas sobre incidência e mortalidade por câncer nos Estados Unidos entre 2003-2005 e 2006. A probabilidade de desenvolver câncer ao longo da vida é de 1 em 2 para homens e 1 em 3 para mulheres. Câncer é a segunda maior causa de morte nos EUA, respondendo por 23,1% dos óbitos em 2006, atrás apenas de doenças cardíacas. As taxas de mortalidade por câncer e doenças cardíacas nos EUA diminuíram entre 1991 e 2006.
41 autoimagem e resiliência no tratamento oncológicoONCOcare
O documento discute a autoimagem e resiliência no tratamento oncológico. Aborda conceitos como imagem corporal, como ela é afetada pelo câncer e como pode ser reestruturada. Também discute modelos salutogênicos e psicologia positiva, focando nos aspectos positivos dos seres humanos. Finalmente, explica o conceito de resiliência e como ele é relevante nos cuidados em psico-oncologia.
40 laserterapia bucal no tratamento oncológicoONCOcare
O documento discute o uso da laserterapia bucal no tratamento da mucosite oral causada por radioterapia e quimioterapia para câncer de cabeça e pescoço. A mucosite oral é uma complicação comum nesses tratamentos e causa dor, disfagia e desconforto, podendo levar à interrupção do tratamento oncológico. A laserterapia mostra evidência para prevenir e aliviar os sintomas da mucosite oral.
O documento discute as modalidades terapêuticas e complicações relacionadas ao tratamento cirúrgico de câncer de cabeça e pescoço. A cirurgia depende da localização do tumor e objetiva remover estruturas envolvidas. As complicações podem ser anatômicas, fisiológicas ou técnicas, e incluem infecções, fístulas, hemorragias, necrose de retalhos e sequelas neurais. Um bom planejamento e cuidados pós-operatórios são essen
38 manutenção de sondas e cuidados na administraçãoONCOcare
O documento fornece informações sobre cuidados com sondas enterais e dietas enterais. Ele discute a nutrição enteral, fatores de risco para desnutrição, vias de administração como sonda nasoenteral, gastrostomia e gastrojejunostomia, e cuidados de enfermagem necessários para cada via de administração.
O documento descreve a história e aplicações da radioterapia no tratamento do câncer, incluindo o uso de raios-X, teleterapia e braquiterapia. Detalha os efeitos das radiações em células e tecidos, além das indicações e modalidades da radioterapia no tratamento de neoplasias e outras doenças.
36 clínica e epidemiologia dos tumores de cabeça e pescoçoONCOcare
O documento discute a anatomia, histologia, epidemiologia, diagnóstico e tratamento dos tumores de cabeça e pescoço. Os tumores de cabeça e pescoço são mais comuns na cavidade oral, faringe e laringe, afetando principalmente homens devido ao tabagismo e etilismo. O tratamento envolve cirurgia, radioterapia e quimiorradioterapia de forma multidisciplinar visando a preservação de órgãos e melhores resultados para os pacientes.
35 vias alternativas de alimentação - quando indicar e como prescreverONCOcare
O documento discute vias alternativas de alimentação para pacientes com câncer de cabeça e pescoço, incluindo terapia nutricional enteral, critérios de indicação, locais de sondaje e tipos de formulação. Também aborda a importância da avaliação nutricional, reabilitação da deglutição e acompanhamento do paciente durante e após o tratamento.
34 tratamento adjuvante do câncer de testículo fatores prognósticos, esquem...ONCOcare
Este documento discute fatores prognósticos e opções de tratamento para câncer de testículo estádio I. Para seminoma, tamanho do tumor maior que 4cm e invasão de rede testicular são fatores de pior prognóstico. Para não-seminoma, a presença de carcinoma embrionário é fator de pior prognóstico. Opções de tratamento incluem observação, radioterapia, quimioterapia e disseção linfonodal retroperitoneal. Toxicidades tardias como segundo tumor primário são mais comuns após radioterapia.
33 tratamento da doença androgênio-resistenteONCOcare
1) O documento discute tratamentos para câncer de próstata resistente a hormônios, incluindo quimioterapia de segunda linha com docetaxel ou cabazitaxel.
2) Estudos mostraram que docetaxel aumenta a sobrevida global em pacientes com doença metastática resistente a hormônios em relação a mitoxantrona.
3) O estudo TROPIC mostrou que cabazitaxel também aumenta a sobrevida global nesses pacientes em comparação a mitoxantrona, após fal
32 radioterapia adjuvante x resgate - o que a evidência nos mostraONCOcare
1) A radioterapia adjuvante melhora o controle local e reduz as recidivas em pacientes com fatores de risco pós-prostatectomia como margens positivas e doença extraprostática.
2) A radioterapia de resgate também fornece bons resultados em termos de sobrevida livre de doença em pacientes com aumento inicial do PSA após a cirurgia.
3) Existe um debate em andamento sobre os critérios ideais para a indicação da radioterapia adjuvante versus a radioterapia de resgate preco
31 qual o melhor programa de quimioterapia a ser combinado com radioterapiaONCOcare
Baseado em estudos de fase III, o melhor programa de quimioterapia a ser combinado com radioterapia no tratamento do câncer de pulmão é o esquema com dose plena de carboplatina e etoposídeo ou o esquema com dose plena de carboplatina e pemetrexed. Outras opções aceitáveis incluem esquemas radiosensibilizantes com carboplatina ou paclitaxel administrados semanalmente durante a radioterapia.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
6. GOG 111 andOV 10(Intergroup)
McGuireetal, N Eng J Med, 1996;
n=386,suboptimalcytoreduction III/IV
SLPSG
PT 18m 38m
PC 13m 24m
Piccartetal, J Nat CancerInst, 2000;
n=668, debulkingsurgery, II-IV
SLPSG
PT 17m 35m
PC 12m 25m
7. GOG 172
Standard arm IV
D1 Paclitaxel IV 135mg/m2/24hs
D1 D2
D2 CisplatinIV 75mg/m2
IV IV
Experimental arm IV/IP D1 Paclitaxel EV 135mg/m2/24hs
D2 CisplatinIP100mg/m2
D1 D2 D8
D8 PaclitaxelIP60mg/m2
IVIP IP
Armostrong e al, NEJM, 2006;
N=429, optimaldebulkingsurgery, stage III
SLPSG
PT IV 19m 50m
PT IV/IP 24m 65m
Only 42% ofptscompletedtreat. IV/IP arm
8. GOG randomized studies: IV vs IP
PFS (m) %Advantage OS (m) %Advantage
IV IP IV IP
Alberts -- -- 41 49
Markman 22 28 27 52 63
Armstrong 19 24 20 50 65 25
* Statisticallysignificant : p < 0.05
9. CarboplatinAUC 6 + Paclitaxel
R 180mg/m2
A
N
D
q 21 days x 6 cycles
AdvancedOvaria
O
nCancer M
I CarboplatinAUC 6 + Paclitaxel
(n = 637) Z
A 80mg/m2 d1,8,15
T
I q 21 days x 6 cycles
O
N
Katsumata N, Lancet: 374, 2009
11. PrimaryCitoreduc Platinun-CT
R
A tion x 6 cycles
N
D
AdvancedOv O
arianCancer M
I
(III/IV) Z
A
(n = 718) T
I Platinun-CT Platinun-CT
IntervalCytored
O
N x 3 cycles uction x 3 cycles
Vergote I, NEJM: 363 2010
14. Citoreduction CT
CT Citoreductio
n
Pos-op Death 2.5% 0.7%
Hemorraghe G III/IV
Infection 7.1%
8.1% 4.1%
1.7%
DVT/PE 2.5% 0%
Vergote I, NEJM: 363 2010
15. GOG-0218: Scheme Arm
Carboplatin(C) AUC 6
Paclitaxel (P) 175 mg/m2
I
R
First-line : Epithelial A Placebo
OV, PP or F N
D 1:1:1 Carboplatin(C) AUC 6
• Stage III optimal
• Stage III suboptimal
O
M Paclitaxel (P) 175 mg/m2
II
• Stage IV
I
n=1800 (planned) Z
BEV 15 mg/kg Placebo
E
Carboplatin(C) AUC 6
Stratification III
• PS Paclitaxel (P) 175 mg/m2
• Stage/Citoreduction BEV 15 mg/kg
15 months
16. GOG-218: Progression-Free Survival
Arm I Arm II Arm III
1.0 CP CP + BEV CP + BEV BEV
(n=625) (n=625) (n=623)
Proportion surviving progression free
0.9 423 418 360
Patients with event, n (%)
(67.7) (66.9) (57.8)
0.8 Median PFS, months 10.3 11.2 14.1
0.7 Stratified analysis HR 0.908 0.717
(95% CI) (0.759–1.040) (0.625–0.824)
0.6 One-sided p-value (log rank) 0.080a <0.0001a
0.5
0.4
0.3
0.2
CP (Arm I)
0.1 + BEV (Arm II)
+ BEV → BEV maintenance (Arm III)
0
0 12 24 36
Months since randomization
17. GOG-218: Select Adverse Events
Onset between cycle 2 and 30 days after date of last treatment
Arm I Arm II Arm III
CP CP + BEV CP + BEV BEV
Adverse event (grade when limited), n (%)
(n=601) (n=607) (n=608)
GI eventsa (grade ≥2) 7 (1.2) 17 (2.8) 16 (2.6)
Hypertension (grade ≥2) 43 (7.2)b 100 (16.5)b 139 (22.9)b
Proteinuria (grade ≥3) 4 (0.7) 4 (0.7) 10 (1.6)
Pain (grade ≥2) 250 (41.7) 252 (41.5) 286 (47.1)
Neutropenia (grade ≥4) 347 (57.7) 384 (63.3) 385 (63.3)
Febrile neutropenia 21 (3.5) 30 (4.9) 26 (4.3)
Venous thromboembolic event 35 (5.8) 32 (5.3) 41 (6.7)
Arterial thromboembolic event 5 (0.8) 4 (0.7) 4 (0.7)
CNS bleeding 0 0 2 (0.3)
Non-CNS bleeding (grade ≥3) 5 (0.8) 8 (1.3) 13 (2.1)
RPLS 0 1 (0.2) 1 (0.2)
RPLS = reversible posterior leukoencephalopathy syndrome
aPerforation/fistula/necrosis/leak
bp<0.05
18. ICON 7: Scheme
CarboplatinAUC6* q3w
Stage I or IIa (grade Paclitaxel 175mg/m2 q3w
3 or clear cell) or
stage IIb–IV EOC,
PP, FTC CarboplatinAUC6* q3w
(n=1,520) Paclitaxel 175mg/m2 q3w
Bevacizumab 7.5mg/kg q3w
• Open-label study 18 cycles
• Endpoints
– primary: PFS
– secondary: RR, OS, safety, QoL, cost effectiveness, translational
• Stratification
– FIGO stage/surgery; time since surgery; GCIG group
21. GOG 218 and ICON 7: Comparison of Trials
Trial GOG-0218 ICON7
Number of patients 1,800 1,520
Setting/design •Double-blinded, placebo-controlled • Open-label
•First-line setting •First-line setting
•3-arm study: • 2-arm study:
Arm I: CT + placebo Arm A: carboplatin/paclitaxel (CT)
Arm II: CT + Bevacizumab (5 cycles) Arm B: CT + Bevacizumab
Arm III: CT + Bevacizumab (extended) •Bevacizumab continued for 12 months
•Bevacizumab continued for 16 months •Bevacizumab dose: 2.5mg/kg/week
•Bevacizumab dose: 5mg/kg/week •Flexibility in AUC for carboplatin
•Rigid AUC for carboplatin
Patient population Post-cytoreductive surgery Post-cytoreductive surgery
Sub-optimally debulked stage III/IV I or IIa (grade 3 or clear-cell histology)
Macroscopic optimally debulked stage III IIb–IV (all grades and histological types)
Target disease Epithelial ovarian, fallopian tube or primary Epithelial ovarian, fallopian tube or primary
peritoneal cancer peritoneal cancer
Stratification • PS (0–1 vs 2) • FIGO stage
• Stage (III vs IV) • ≤ vs>4 weeks after surgery
• GCIG group
Primary endpoint • Investigator-assessed PFS data • Investigator-assessed PFS data
• Exploratory: IRC-assessed PFS data
22. P
R
I 0 3 6 12 18 24
M
A Refractory Months
R
Y
T
Resistent
R
E
Sensitive
A
T
M
E Highlysensitive
N
T
25. ICON-4/AGO-OVAR-2.2 Trial
CarboplatinAUC 5 a 6 EV
R OR
A
N Cisplatin75mg/m2 EV
D q 21 days
Platinum- O
sensitiveovariancancer M
ΔT >6 m I CarboplatinAUC 5 EV
Z OR
A Cisplatin50mg/m2 EV
T +
I Paclitaxel 175mg/m2 EV
O Q 21 days
N
Parmar MK, Lancet: 361, 2003
27. CALYPSO: Scheme
R
A
Inclusion Criteria: N CarboplatinAUC 5 EV + Paclitaxel 175
D mg/m2 IV 3
• Platinum-sensitive (> 6 O
m) M q21dx6 cycles
• 1 or 2 prior platinum- I
based CT Z
• Measurable disease A
(image or CA125) T CarboplatinAUC 5 EV + DoxoLipossomal
I 30 mg/m2 IV 1 h
O
N q 28 days x6 cycles*
*or until PD in patients with stable disease or response
Pujades E etal, J ClinOncol, 2010